Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.
- Status
- RECRUITING
- Phase
- PHASE1
RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada
- Status
- COMPLETED
- Phase
- N/A
OPTIMISE-CKD Drug Utilization
- Status
- COMPLETED
- Phase
- N/A
Benralizumab Patient Access Programme Study: Retrospective Study in UK Severe Asthma Centres
- Status
- COMPLETED
- Phase
- N/A
Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Andexanet Alfa in Patients Requiring Urgent Surgery or Procedure
- Status
- WITHDRAWN
- Phase
- PHASE3
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as 1L Treatment for the Chinese Patients With Unresectable Biliary Tract Cancers (BTC)
- Status
- COMPLETED
- Phase
- PHASE3
Tezepelumab PRO Study
- Status
- COMPLETED
- Phase
- N/A
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- Status
- RECRUITING
- Phase
- NA
A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693
- Status
- COMPLETED
- Phase
- PHASE1
National Register of Actionable Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation
- Status
- COMPLETED
- Phase
- N/A
Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in China
- Status
- COMPLETED
- Phase
- N/A